← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

AMN Healthcare Services, Inc. (AMN) 10-Year Financial Performance & Capital Metrics

AMN • • Industrial / General
HealthcareHealthcare FacilitiesHealthcare Staffing & Workforce SolutionsHealthcare Staffing Agencies
AboutAMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, telehealth, credentialing, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, and Merritt Hawkins, as well as AMN Revenue Cycle Solutions and AMN Language Services. The company was founded in 1985 and is based in Dallas, Texas.Show more
  • Revenue $2.98B -21.3%
  • EBITDA $71M -85.8%
  • Net Income -$147M -169.8%
  • EPS (Diluted) -3.85 -171.8%
  • Gross Margin 30.81% -6.6%
  • EBITDA Margin 2.38% -81.9%
  • Operating Margin -3.44% -138.5%
  • Net Margin -4.93% -188.6%
  • ROE -19.11% -185.1%
  • ROIC -3.91% -130.7%
  • Debt/Equity 1.55 -4.4%
  • Interest Coverage -1.47 -123.5%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Share count reduced 2.9% through buybacks
  • ✓Trading at only 0.8x book value
  • ✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

  • ✗Weak momentum: RS Rating 17 (bottom 17%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y11.16%
5Y6.07%
3Y-9.19%
TTM-11.42%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-619.46%

EPS CAGR

10Y-
5Y-
3Y-
TTM-620.91%

ROCE

10Y Avg17.51%
5Y Avg14.71%
3Y Avg13.88%
Latest-4.96%

Peer Comparison

Healthcare Staffing Agencies
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
AMNAMN Healthcare Services, Inc.588.5M15.32-3.98-21.26%-10.14%-42.76%40.7%1.55
CCRNCross Country Healthcare, Inc.276.82M8.45-19.20-33.46%-1.39%-3.84%40.24%0.01

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+1.46B1.9B1.99B2.14B2.22B2.39B3.98B5.24B3.79B2.98B
Revenue Growth %0.41%0.3%0.05%0.07%0.04%0.08%0.66%0.32%-0.28%-0.21%
Cost of Goods Sold+993.7M1.28B1.34B1.44B1.48B1.6B2.67B3.53B2.54B2.06B
COGS % of Revenue0.68%0.67%0.68%0.67%0.67%0.67%0.67%0.67%0.67%0.69%
Gross Profit+469.36M619.72M644.42M696.38M743.47M791.78M1.31B1.72B1.25B919.38M
Gross Margin %0.32%0.33%0.32%0.33%0.33%0.33%0.33%0.33%0.33%0.31%
Gross Profit Growth %0.48%0.32%0.04%0.08%0.07%0.06%0.65%0.31%-0.27%-0.26%
Operating Expenses+340.48M428.09M431.98M493.56M566.55M642.51M831.6M1.07B911.15M1.02B
OpEx % of Revenue0.23%0.23%0.22%0.23%0.25%0.27%0.21%0.2%0.24%0.34%
Selling, General & Admin319.53M398.47M399.7M452.32M508.03M549.75M730.45M936.58M756.24M632.49M
SG&A % of Revenue0.22%0.21%0.2%0.21%0.23%0.23%0.18%0.18%0.2%0.21%
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses20.95M29.62M32.28M41.24M58.52M92.77M101.15M133.01M154.91M389.56M
Operating Income+128.88M191.63M212.44M202.83M176.91M149.26M478M647.1M338.43M-102.67M
Operating Margin %0.09%0.1%0.11%0.09%0.08%0.06%0.12%0.12%0.09%-0.03%
Operating Income Growth %0.9%0.49%0.11%-0.05%-0.13%-0.16%2.2%0.35%-0.48%-1.3%
EBITDA+149.83M221.25M244.72M244.06M235.44M243.45M581.7M784.21M499.36M71.11M
EBITDA Margin %0.1%0.12%0.12%0.11%0.11%0.1%0.15%0.15%0.13%0.02%
EBITDA Growth %0.79%0.48%0.11%-0%-0.04%0.03%1.39%0.35%-0.36%-0.86%
D&A (Non-Cash Add-back)20.95M29.62M32.28M41.24M58.52M94.19M103.7M137.11M160.93M173.78M
EBIT128.88M191.63M212.44M202.83M176.91M149.26M478M647.1M338.43M-102.67M
Net Interest Income+-7.79M-15.46M-19.68M-16.14M-28.43M-57.74M-34.08M-40.4M-54.14M-69.9M
Interest Income0000000000
Interest Expense7.79M15.46M19.68M16.14M28.43M57.74M34.08M40.4M54.14M69.9M
Other Income/Expense-7.79M-15.46M-19.68M-16.14M-28.43M-57.74M-34.08M-40.4M-54.14M-69.9M
Pretax Income+121.09M176.17M192.76M186.69M148.49M91.52M443.92M606.7M284.29M-172.57M
Pretax Margin %0.08%0.09%0.1%0.09%0.07%0.04%0.11%0.12%0.08%-0.06%
Income Tax+39.2M70.33M60.2M44.94M34.5M20.86M116.53M162.65M73.61M-25.59M
Effective Tax Rate %0.68%0.6%0.69%0.76%0.77%0.77%0.74%0.73%0.74%0.85%
Net Income+81.89M105.84M132.56M141.74M113.99M70.67M327.39M444.05M210.68M-146.98M
Net Margin %0.06%0.06%0.07%0.07%0.05%0.03%0.08%0.08%0.06%-0.05%
Net Income Growth %1.47%0.29%0.25%0.07%-0.2%-0.38%3.63%0.36%-0.53%-1.7%
Net Income (Continuing)81.89M105.84M132.56M141.74M113.99M70.67M327.39M444.05M210.68M-146.98M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)+1.682.152.682.912.401.486.819.905.36-3.85
EPS Growth %1.43%0.28%0.25%0.09%-0.18%-0.38%3.6%0.45%-0.46%-1.72%
EPS (Basic)1.722.212.772.992.441.496.879.965.38-3.85
Diluted Shares Outstanding48.84M49.27M49.43M48.67M47.59M47.69M48.05M44.87M39.34M38.19M
Basic Shares Outstanding47.52M47.95M47.81M47.37M46.7M47.42M47.69M44.59M39.17M38.19M
Dividend Payout Ratio----------

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+375.63M450.63M474.15M482.17M560.5M533.74M1.35B1.09B841.68M594.91M
Cash & Short-Term Investments9.58M10.62M15.15M13.86M82.98M29.21M180.93M64.52M32.94M10.65M
Cash Only9.58M10.62M15.15M13.86M82.98M29.21M180.93M64.52M32.94M10.65M
Short-Term Investments0000000000
Accounts Receivable332.49M391.57M407.41M416.81M431.38M450.08M1.03B953.25M746.54M519.98M
Days Sales Outstanding82.9575.1374.7871.2270.8668.6394.2566.3671.9163.61
Inventory25.52M34.46M57.91M39.54M038.85M0000
Days Inventory Outstanding9.379.8115.7310.02-8.85----
Other Current Assets20.04M34.25M35.09M39.09M34.46M1.96M66.83M57.16M40.32M41.77M
Total Non-Current Assets+504.8M736.25M779.8M1.01B1.37B1.82B1.78B1.79B2.08B1.82B
Property, Plant & Equipment50.13M59.95M73.43M90.42M194.7M193.91M154.88M165.54M225.93M218.38M
Fixed Asset Turnover29.18x31.73x27.08x23.62x11.41x12.34x25.72x31.67x16.77x13.66x
Goodwill204.78M341.75M340.6M438.51M595.55M864.49M892.34M935.36M1.11B897.46M
Intangible Assets174.97M245.72M227.1M326.15M398.47M564.91M514.46M476.83M474.13M381.36M
Long-Term Investments-22.43M-21.42M-27.04M-27.33M000000
Other Non-Current Assets74.92M88.82M138.68M155.48M182.42M129.26M221.15M216.97M271.1M297.78M
Total Assets+880.43M1.19B1.25B1.49B1.93B2.35B3.13B2.89B2.92B2.42B
Asset Turnover1.66x1.60x1.59x1.43x1.15x1.02x1.27x1.82x1.30x1.24x
Asset Growth %0.29%0.35%0.06%0.19%0.29%0.22%0.33%-0.08%0.01%-0.17%
Total Current Liabilities+251.02M274.79M265.27M307.27M378.11M422.96M969.39M857.93M656.12M545.78M
Accounts Payable84.94M85.36M73.21M82.43M102.55M107.45M339.01M373.32M177.11M100.92M
Days Payables Outstanding31.224.2919.8820.925.3124.4846.2638.6425.4517.84
Short-Term Debt37.5M3.75M0004.69M0000
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities25.68M68.76M62.26M88.79M149.71M167.37M250.48M251.95M223.39M237.53M
Current Ratio1.50x1.64x1.79x1.57x1.48x1.26x1.39x1.27x1.28x1.09x
Quick Ratio1.39x1.51x1.57x1.44x1.48x1.17x1.39x1.27x1.28x1.09x
Cash Conversion Cycle61.1260.6570.6360.35-53----
Total Non-Current Liabilities+281.56M462.71M426.16M546.46M816.8M1.11B1B986.78M1.44B1.16B
Long-Term Debt180.99M359.19M319.84M440.61M617.16M857.96M842.32M843.5M1.3B1.06B
Capital Lease Obligations000091.21M77.8M13.36M9.36M37.6M35.73M
Deferred Tax Liabilities22.43M21.42M27.04M27.33M46.62M047.81M22.71M23.35M0
Other Non-Current Liabilities78.13M103.52M106.31M77.66M61.81M107.91M96.99M111.21M71.38M71.72M
Total Liabilities532.57M737.5M691.43M853.73M1.19B1.53B1.97B1.84B2.09B1.71B
Total Debt+218.49M362.94M319.84M440.61M722.31M955.48M867.07M860.96M1.35B1.1B
Net Debt208.91M352.32M304.7M426.75M639.33M926.27M686.14M796.43M1.32B1.09B
Debt / Equity0.63x0.81x0.57x0.69x0.98x1.17x0.75x0.82x1.62x1.55x
Debt / EBITDA1.46x1.64x1.31x1.81x3.07x3.92x1.49x1.10x2.70x15.44x
Net Debt / EBITDA1.39x1.59x1.25x1.75x2.72x3.80x1.18x1.02x2.64x15.29x
Interest Coverage16.54x12.39x10.80x12.56x6.22x2.59x14.03x16.02x6.25x-1.47x
Total Equity+347.86M449.38M562.53M638.99M736.74M819.68M1.16B1.04B831.26M706.62M
Equity Growth %0.36%0.29%0.25%0.14%0.15%0.11%0.42%-0.1%-0.2%-0.15%
Book Value per Share7.129.1211.3813.1315.4817.1924.1923.2621.1318.50
Total Shareholders' Equity347.86M449.38M562.53M638.99M736.74M819.68M1.16B1.04B831.26M706.62M
Common Stock477K481K484K488K493K496K498K501K504K507K
Retained Earnings-96.17M9.67M142.23M286.06M400.05M469.56M796.95M1.24B1.45B1.3B
Treasury Stock0-13.26M-33.42M-100.44M-119.14M-119.14M-121.83M-698.6M-1.13B-1.13B
Accumulated OCI-183K1K-112K151K152K40K-295K-939K-423K-11K
Minority Interest0000000000

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+57.05M131.85M115.26M226.99M224.86M256.83M305.36M653.73M372.17M320.42M
Operating CF Margin %0.04%0.07%0.06%0.11%0.1%0.11%0.08%0.12%0.1%0.11%
Operating CF Growth %1.06%1.31%-0.13%0.97%-0.01%0.14%0.19%1.14%-0.43%-0.14%
Net Income81.89M105.84M132.56M141.74M113.99M70.67M327.39M444.05M210.68M-146.98M
Depreciation & Amortization20.95M29.62M32.28M41.24M58.52M94.19M103.7M137.11M160.93M173.78M
Stock-Based Compensation10.28M11.4M10.24M10.81M16.24M20.46M25.22M30.07M18.02M23.32M
Deferred Taxes12.68M-9.42M5.61M-667K913K-21.63M-16.29M-24.61M-12.93M-51.07M
Other Non-Cash Items1.58M11.12M12.85M2.25M16.22M26.01M8.84M67.68M45.6M235.46M
Working Capital Changes-70.33M-16.7M-78.27M31.61M18.98M67.13M-143.49M-558K-50.13M85.91M
Change in Receivables-98.02M-57.16M-10.64M-10.58M5.71M-8.61M-585.27M20.04M224.85M219.44M
Change in Inventory-7.34M-3.34M-32.63M14.56M-1.93M-5.56M-256.12M000
Change in Payables29.61M17.7M-7.86M17.15M1.93M5.56M256.12M000
Cash from Investing+-116.83M-257.36M-33.45M-279.34M-291.82M-538.17M-107.4M-170.71M-412.49M-79.94M
Capital Expenditures-27.01M-21.96M-26.53M-36.39M-36.46M-39.1M-53.66M-75.83M-103.69M-80.89M
CapEx % of Revenue0.02%0.01%0.01%0.02%0.02%0.02%0.01%0.01%0.03%0.03%
Acquisitions----------
Investments----------
Other Investing-3M-5.91M-8.62M-10.67M-13.29M-7.66M-8.99M-26.61M-26.6M-6.76M
Cash from Financing+56.2M126.29M-77.19M37.51M136.6M211.49M-34.9M-591.87M10.73M-259.45M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing-796K-10.13M-12.97M-15.48M-24.7M-22.13M-10.33M-15.1M-24.23M-9.45M
Net Change in Cash----------
Free Cash Flow+30.04M109.89M88.73M190.61M188.4M217.72M251.69M572.81M266.78M239.53M
FCF Margin %0.02%0.06%0.04%0.09%0.08%0.09%0.06%0.11%0.07%0.08%
FCF Growth %2.52%2.66%-0.19%1.15%-0.01%0.16%0.16%1.28%-0.53%-0.1%
FCF per Share0.622.231.803.923.964.575.2412.776.786.27
FCF Conversion (FCF/Net Income)0.70x1.25x0.87x1.60x1.97x3.63x0.93x1.47x1.77x-2.18x
Interest Paid-5.81M8.06M17.94M21.28M23.73M22.65M38.09M37.52M48.1M61.03M
Taxes Paid-33.13M73.37M73.75M30.59M37.75M46.26M106.38M213.81M78.26M28.15M

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)27.1%26.55%26.2%23.59%16.57%9.08%33.04%40.26%22.47%-19.11%
Return on Invested Capital (ROIC)20.08%21.16%19.09%15.74%10.87%7.17%19.95%26.32%12.73%-3.91%
Gross Margin32.08%32.58%32.41%32.6%33.46%33.08%32.87%32.74%32.98%30.81%
Net Margin5.6%5.56%6.67%6.64%5.13%2.95%8.22%8.47%5.56%-4.93%
Debt / Equity0.63x0.81x0.57x0.69x0.98x1.17x0.75x0.82x1.62x1.55x
Interest Coverage16.54x12.39x10.80x12.56x6.22x2.59x14.03x16.02x6.25x-1.47x
FCF Conversion0.70x1.25x0.87x1.60x1.97x3.63x0.93x1.47x1.77x-2.18x
Revenue Growth41.22%30.02%4.53%7.42%4.03%7.72%66.45%31.6%-27.73%-21.26%

Revenue by Segment

2015201620172018201920202021202220232024
Locum Tenens Staffing385.09M424.24M430.62M393.37M324.65M---464.8M566.35M
Locum Tenens Staffing Growth-10.17%1.50%-8.65%-17.47%----21.85%
Permanent Placement--------86.32M58.41M
Permanent Placement Growth----------32.33%
Nurse and Allied Healthcare Staffing1.02B1.19B1.24B1.31B1.42B1.7B2.99B3.98B--
Nurse and Allied Healthcare Staffing Growth-15.74%4.51%5.49%8.68%19.67%75.96%33.19%--
Physician and Leadership Solutions-----466.62M594.24M697.95M--
Physician and Leadership Solutions Growth------27.35%17.45%--
Technology And Workforce Solutions-----227.78M399.89M562.84M--
Technology And Workforce Solutions Growth------75.56%40.75%--
Other Workforce Solutions-292.89M319.3M436.19M477.49M-----
Other Workforce Solutions Growth--9.02%36.61%9.47%-----
Physician Permanent Placement Services54.04M---------
Physician Permanent Placement Services Growth----------

Frequently Asked Questions

Growth & Financials

AMN Healthcare Services, Inc. (AMN) reported $2.72B in revenue for fiscal year 2024. This represents a 206% increase from $887.5M in 2011.

AMN Healthcare Services, Inc. (AMN) saw revenue decline by 21.3% over the past year.

AMN Healthcare Services, Inc. (AMN) reported a net loss of $275.5M for fiscal year 2024.

Dividend & Returns

AMN Healthcare Services, Inc. (AMN) has a return on equity (ROE) of -19.1%. Negative ROE indicates the company is unprofitable.

AMN Healthcare Services, Inc. (AMN) generated $222.8M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.